tradingkey.logo

BUZZ-Illumina extends fall as Bernstein flags competition from Roche's device

ReutersFeb 21, 2025 7:33 PM

Shares of gene-sequencing equipment maker Illumina ILMN.O fall 2.7% to $94.6

Bernstein analysts say Roche's ROG.S new gene sequencing device designed to decode diseases such as cancer, immune disorders and neurodegenerative diseases outperforms ILMN's devices

ROG unveiled the device on Thursday, featuring gene sequencing capabilities that provides detailed insights into genetics, genomics and cell biology

ILMN shares had closed down 5.6% on Thursday, following the news

Bernstein raises questions about the accuracy of the ROG device but said it could be a serious threat to ILMN in some applications

ILMN has fallen 24.8% in the past 12 months

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI